FdaApplication
ANDA 218668
Identifiers
- fda_app_no: ANDA218668
Properties
| Property | Value |
|---|---|
| applicant_name | DEXCEL PHARMA TECHNOLOGIES LTD |
| application_type | ANDA |
| approval_date | 2024-12-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | 22MG | TABLET, EXTENDED RELEASE;ORAL |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products